Berubicin Shines as Promising Brain Cancer Treatment in Phase 2 GBM Trial: A New Hope with Enhanced Safety
trial was a randomized,controlled study comparing Berubicin to Lomustine in patients with recurrent GBM. Key aspects of the trial design included: Patient Population: Adults with recurrent or progressive GBM who had previously received standard treatment. Treatment Arms: Patients were randomly assigned to receive either Berubicin or Lomustine. Primary Endpoint: overall survival (OS). Secondary Endpoints: Progression-free … Read more